Parkinson's disease and immunological abnormalities: increase of HLA‐DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Acta Neurologica Scandinavica

• Publication date

  1994-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1600-0404.1994.tb02699.xPMID 7847055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of the histocompatibility glycoprotein HLA-DR in neurological disease

  2004cited by this paper
• γδ+ T cells are increased in patients with Parkinson's disease

  1994cited by this paper
• gamma delta+ T cells are increased in patients with Parkinson's disease.

  1994cited by this paper
• Alterations in Function and Phenotype of Monocytes from Patients with Septic Disease: Predictive Value and New Therapeutic Strategies

  1993cited by this paper
• Biology of Adult Human Microglia in Culture: Comparisons with Peripheral Blood Monocytes and Astrocytes

  1992cited by this paper
• Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivo.

  1992cited by this paper
• Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCRα,β+ cells but abnormal proportions of TCRα,β+, TCRγ,δ+, and CD4+CD45RA+ cells: Evidence for an inefficient release of mature T cells by the DS thymus☆

  1992cited by this paper
• Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus.

  1992cited by this paper
• Differential interleukin secretion by in vitro activated human CD45RA and CD45RO CD4+ T cell subsets.

  1992cited by this paper
• The changing 19th‐century view of epilepsy as reflected in the West Riding Lunatic Asylum Medical Reports, 1871–1876, vols 1–6

  1992cited by this paper
• Brain macrophages: evaluation of microglia and their functions.

  1992cited by this paper
• The synergy between naive and memory T cells during activation.

  1991cited by this paper
• T‐lymphocyte entry into the central nervous system

  1991cited by this paper
• The immunological status in Parkinson's disease.

  1991cited by this paper
• Alterations in function and phenotype of monocytes from patients with septic disease--predictive value and new therapeutic strategies.

  1991cited by this paper
• Vault immunofluorescence in the brain: new insights regarding the origin of microglia

  1991cited by this paper
• Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis.

  1991cited by this paper
• A Distinct Wave of Human T Cell Receptor Y/b Lymphocytes in the Early Fetal Thymus: Evidence for Controlled Gene Rearrangement and Cytokine Production

  1990cited by this paper
• Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire

  1990cited by this paper
• Decreased suppressor-inducer T lymphocytes in multiple sclerosis and other neurological diseases.

  1990cited by this paper
• B cells expressing CD5 are increased in cerebrospinal fluidof patients with multiple sclerosis

  1990cited by this paper
• Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.

  1990cited by this paper
• A distinct wave of human T cell receptor gamma/delta lymphocytes in the early fetal thymus: evidence for controlled gene rearrangement and cytokine production

  1990cited by this paper
• Selective expression of CD45 isoforms and of maturation antigens during human thymocyte differentiation: observations and hypothesis.

  1989cited by this paper
• Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human astrocytes

  1989cited by this paper
• Decreased expression of HLA-DR antigens on monocytes in patients with multiple sclerosis.

  1989cited by this paper
• Decrease of suppressor inducer (cd4+ 2h4+) t cells in multiple sclerosis cerebrospinal fluid

  1989cited by this paper
• Lymphocyte subsets in the cerebrospinal fluid in active multiple sclerosis

  1989cited by this paper
• Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets.

  1988cited by this paper
• Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

  1988cited by this paper
• A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.

  1987cited by this paper
• Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis.

  1987cited by this paper
• Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients.

  1987cited by this paper
• Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.

  1987cited by this paper
• Monocytes Become Macrophages; They Do Not Become Microglia: A Light and Electron Microscopic Autoradiographic Study Using 125‐lododeoxyuridine

  1986cited by this paper
• Immune functions in Parkinson's disease lymphocyte subsets, concanavalin A-induced suppressor cell activity and in vitro immunoglobulin production.

  1985cited by this paper
• Antigen-presenting function of the macrophage.

  1984cited by this paper
• Immune functions in Parkinson's disease.

  1984cited by this paper
• Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon.

  1983cited by this paper
• Prostaglandins modulate macrophage Ia expression

  1982cited by this paper
• The Origin and Nature of Microglia

  1981cited by this paper
• Thymic deficiency in Down's syndrome.

  1979cited by this paper
• “Ia‐like” antigens on human T cells

  1979cited by this paper
• Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity

  1978cited by this paper
• Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

  1977cited by this paper
• Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

  1977cited by this paper
• Parkinsonism

  1967cited by this paper

• Colostrum extracellular vesicles are neuroprotective in models of Parkinson's disease

  2026cites this paper
• “Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson’s disease”

  2025cites this paper
• Integrated Stress Response Signatures Drive Monocyte Dysfunction in GBA1- and LRRK2-Linked Parkinson’s Disease

  2025cites this paper
• Immune and metabolic signatures characterise constipation-driven endophenotypes in Parkinson’s disease

  2025cites this paper
• Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson’s disease

  2025cites this paper
• Advanced clinical stage Parkinson’s disease is linked to proinflammatory and regulatory blood cell populations

  2025cites this paper
• Multi-omics dissection of Parkinson’s patients in subgroups associated with motor and cognitive severity

  2025cites this paper
• Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson’s disease

  2025cites this paper
• Plant-derived compounds as potential neuroprotective agents in Parkinson's disease.

  2024cites this paper
• A comprehensive review and recent advancement in the application of tannins for treating Parkinson disease

  2024cites this paper
• Epigenetic associations of GPNMB rs199347 variant with alcohol consumption in Parkinson’s disease

  2024cites this paper
• Immune mechanisms and shared immune targets in neurodegenerative diseases

  2024cites this paper
• Genetically predicted immune cells mediate the association between gut microbiota and neuropathy pain

  2024cites this paper
• Alterations of Peripheral Lymphocyte Subsets in Isolated Rapid Eye Movement Sleep Behavior Disorder

  2024cites this paper
• Meningeal lymphatic vessel crosstalk with central nervous system immune cells in aging and neurodegenerative diseases

  2024cites this paper
• Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease

  2024cites this paper
• The R1441C-LRRK2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner

  2023cites this paper
• Immunology and microbiome: Implications for motor systems.

  2023cites this paper
• Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease.

  2023cites this paper
• Emerging roles of leptin in Parkinson's disease: chronic inflammation, neuroprotection and more?

  2022cites this paper
• The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases

  2022cites this paper
• Neuro faces of beneficial T cells: essential in brain, impaired in aging and neurological diseases, and activated functionally by neurotransmitters and neuropeptides

  2022cites this paper
• Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition.

  2022cites this paper
• Specificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases

  2022cites this paper
• Inflammation and immune dysfunction in Parkinson disease

  2022cites this paper
• Extracellular alpha-synuclein: Sensors, receptors, and responses.

  2022cites this paper
• The aging immune system in Alzheimer’s and Parkinson’s diseases

  2022cites this paper
• High resolution 16S rRNA gene Next Generation Sequencing study of brain areas associated with Alzheimer’s and Parkinson’s disease

  2022cites this paper
• Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson’s disease

  2022cites this paper
• Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities

  2022cites this paper
• Dynamic changes in the CD163+ and CCR2+ peripheral monocytes during Parkinson's disease

  2021cites this paper
• Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder

  2021cites this paper
• Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies

  2021cites this paper
• Immune response during idiopathic Parkinson's disease: From humans to animal models

  2021cites this paper
• T-cell dysregulation is associated with disease severity in Parkinson’s Disease

  2021cites this paper
• Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection

  2021cites this paper
• Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.

  2021cites this paper
• Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

  2021cites this paper
• Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System

  2021cites this paper
• Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?

  2020cites this paper
• The effect of vitamin D on restless legs syndrome: prospective self-controlled case study

  2020cites this paper
• Parkinson disease and the immune system — associations, mechanisms and therapeutics

  2020cites this paper
• The rs3129882/rs4248166 in HLA-DRA and rs34372695 in SYT11 are not associated with sporadic Parkinson’s disease in Central Chinese population

  2020cites this paper
• Immunoinflammatory Aspects of Parkinson’s Disease

  2020cites this paper
• [Immunological aspects of Parkinson's disease].

  2020cites this paper
• CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.

  2020cites this paper
• The accelerated aging model reveals critical mechanisms of late-onset Parkinson’s disease

  2020cites this paper
• Lymphoproliferation Impairment and Oxidative Stress in Blood Cells from Early Parkinson’s Disease Patients

  2019cites this paper
• Changes in the Immune System in Parkinson’s Disease

  2019cites this paper
• The key role of T cells in Parkinson's disease pathogenesis and therapy.

  2019cites this paper
• Inflammation, Infectious Triggers, and Parkinson's Disease

  2019cites this paper
• The delta‐opioid receptor and Parkinson’s disease

  2018cites this paper
• CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology

  2018cites this paper
• Updates on immunity and inflammation in Parkinson disease pathology

  2018cites this paper
• Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact

  2018cites this paper
• Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention

  2018cites this paper
• The role of T cells in the pathogenesis of Parkinson’s disease

  2018cites this paper
• Immune system responses in Parkinson's disease: Early and dynamic

  2018cites this paper
• Mitochondria at the Base of Neuronal Innate Immunity in Alzheimer’s and Parkinson’s Diseases

  2018cites this paper
• T Cell Mediated Cytotoxicity in the MPTP Mouse Model of Parkinson's Disease

  2018cites this paper
• Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity

  2017cites this paper
• Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease

  2017cites this paper
• Dopamine, T cells and multiple sclerosis (MS)

  2017cites this paper
• The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases

  2017cites this paper
• Involvement of Innate and Adaptive Immunity in Parkinson's Disease

  2017cites this paper
• Participation of perforin in mediating dopaminergic neuron loss in MPTP-induced Parkinson's disease in mice.

  2017cites this paper
• Explorer Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson ' s disease

  2017cites this paper
• Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease.

  2017cites this paper
• Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis

  2017cites this paper
• Chapter 11 - Dopamine, T Cells, and Multiple Sclerosis: Dopamine Receptors and Direct Effects on T Cells, Dopamine Production in T Cells, Abnormalities in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis, and Their Correction by Treatment

  2016cites this paper
• Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases

  2016influential citation
• Neuroinflammation During Parkinson’s Disease: Key Cells and Molecules Involved in It

  2016cites this paper
• Is Chronic Systemic Inflammation a Determinant Factor in Developing Parkinson’s Disease?

  2016cites this paper
• Inflammation: the Common Link in Brain Pathologies

  2016cites this paper
• In Invivo model of Parkinson ’ s syndrome , concurrent administrations of anti-inflammatory drugs changed behavioral deficits

  2015cites this paper
• Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.

  2015cites this paper
• Clinical Aspects of Inflammation in Parkinson’s Disease

  2014cites this paper
• Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders

  2014cites this paper
• Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

  2014cites this paper
• Vaccination strategies for Parkinson disease

  2014cites this paper
• Clinical Aspects of Infl ammation in Parkinson's Disease

  2014cites this paper
• Innate and Adaptive Immune-Mediated Neuroinflammation and Neurodegeneration in Parkinson’s Disease

  2014cites this paper
• Proinflammatory Chemical Signaling: Cytokines

  2014cites this paper
• Role of the Innate and Adaptive Immune System in the Pathogenesis of PD

  2014cites this paper
• Contrôle de l'activation microgliale par les lymphocytes T dans un modèle murin de neurodégénérescence induite par la 6-OHDA

  2014cites this paper
• Glial-Mediated Inflammation Underlying Parkinsonism

  2013cites this paper
• The Role of β-Adrenergic Blockers in Parkinson’s Disease

  2013cites this paper
• The Role of Innate and Adaptive Immunity in Parkinson's Disease

  2013cites this paper
• Dopamine in the Immune System: Dopamine Receptors in Immune Cells, Potent Effects, Endogenous Production and Involvement in Immune and Neuropsychiatric Diseases

  2012cites this paper
• CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease

  2012cites this paper
• Reduced T helper and B lymphocytes in Parkinson's disease.

  2012cites this paper
• Role of Vitamin D in Parkinson's Disease

  2012cites this paper
• Does Parkinson’s Disease Have an Immunological Basis?

  2012cites this paper
• Inflammation and adaptive immunity in Parkinson's disease.

  2012cites this paper
• La sutura sarduyana en El Cristo de la rue Jacob

  2012cites this paper
• Activated Immune Cells in Parkinson's Disease

  2011cites this paper
• Biomarkers of Parkinson's disease and Dementia with Lewy bodies.

  2011influential citation
• Pathways towards an effective immunotherapy for

  2011cites this paper
• Vasoactive neuropeptides in autoimmune diseases

  2011cites this paper
• Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression.

  2011cites this paper